Last reviewed · How we verify

NCT06062160

The Effect of Therapeutic Touch on Pain and Comfort After Cesarean Section

Completed NA Last updated 19 February 2025
What this trial tests

NA trial testing Therapeutic Touch in Therapeutic Touch in 90 participants. Completed in 1 January 2024.

Timeline
1 January 2022
Primary endpoint
30 September 2023
1 January 2024

Quick facts

Lead sponsorCukurova University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment90
Start date1 January 2022
Primary completion30 September 2023
Estimated completion1 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Cukurova University

Who can join

Adults 18 to 45, female only, with Therapeutic Touch or Postpartum Period. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted as randomized controlled study to evaluate the effect of Therapeutic Touch on acute pain and comfort level in women who delivered by cesarean section. Personal information form was used as data collection form, VAS was used to assess pain, and PPCQ was used to assess comfort. When power analysis was performed, the sample size was calculated to be at least 45 participants for each group (45 experiments, 45 controls). Experimental group received deep Therapeutic Touch by investigators two time at 10th and 40nd hours after cesarean section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Therapeutic Touch

Trials testing the same drug.

Other Cukurova University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06062160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing